SC
FLNA

Steven Cohen’s Filana Therapeutics FLNA Stock Holding History

Steven Cohen’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.8K Sell
11,575
-27,546
-70% -$39.2K ﹤0.01% 3890
2026
Q1 		$66.1K Sell
39,121
-260,458
-87% -$536K ﹤0.01% 3645
2025
Q4 		$593K Buy
+299,579
New +$959K ﹤0.01% 3155
2020
Q4 		– Sell
-125,000
Closed -$1.44M – 1106
2020
Q3 		$1.44M Buy
+125,000
New +$564K 0.01% 741

Other funds holding FLNA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $1.92B AUM 70.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return

Steven Cohen's FLNA Position: Q2 2026 in Review

Steven Cohen reduced its Filana Therapeutics (FLNA) stake by 70% in Q2 2026, selling an estimated $39.2K and leaving 11,575 shares worth $13.8K. The position accounts for ﹤0.01% of the portfolio, ranked #3890.

Steven Cohen first reported a position in FLNA in Q3 2020 and has held it in 4 quarters since. The position peaked at $1.44M in Q3 2020. 85 funds tracked by Wall St. Rank hold FLNA as of Q2 2026.

  • Steven Cohen held 11,575 shares of Filana Therapeutics worth $13.8K as of Q2 2026.
  • Steven Cohen sold 27,546 Filana Therapeutics shares in Q2 2026, an estimated $39.2K.
  • Filana Therapeutics made up ﹤0.01% of Steven Cohen's portfolio in Q2 2026, its #3890 holding.
  • Steven Cohen first reported a position in Filana Therapeutics in Q3 2020 and has held it in 4 quarters since.
  • Steven Cohen's Filana Therapeutics position peaked at $1.44M in Q3 2020.
  • 85 funds tracked by Wall St. Rank held Filana Therapeutics as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.